The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines
Open accessAbstract
BACKGROUND: Sulforaphane (SFN), an isothiocyanate found in cruciferous vegetables, is a common dietary component that has histone deacetylase inhibition activity and exciting potential in cancer prevention. The mechanisms by which SFN imparts its chemopreventive properties are of considerable interest and little is known of its preventive potential for breast cancer. PRINCIPAL FINDINGS: We found that SFN significantly inhibits the viability and proliferation of breast cancer cells in vitro while it has negligible effects on normal breast cells. Inhibition of telomerase has received considerable attention because of its high expression in cancer cells and extremely low level of expression in normal cells. SFN treatment dose- and time-dependently inhibited human telomerase reverse transcriptase (hTERT), the catalytic regulatory subunit of telomerase, in both MCF-7 and MDA-MB-231 human breast cancer cells. DNA methyltransferases (DNMTs), especially DNMT1 and DNMT3a, were also decreased in SFN-treated breast cancer cells suggesting that SFN may repress hTERT by impacting epigenetic pathways. Down-regulation of DNMTs in response to SFN induced site-specific CpG demethylation occurring primarily in the first exon of the hTERT gene thereby facilitating CTCF binding associated with hTERT repression. Chromatin immunoprecipitation (ChIP) analysis of the hTERT promoter revealed that SFN increased the level of active chromatin markers acetyl-H3, acetyl-H3K9 and acetyl-H4, whereas the trimethyl-H3K9 and trimethyl-H3K27 inactive chromatin markers were decreased in a dose-dependent manner. SFN-induced hyperacetylation facilitated the binding of many hTERT repressor proteins such as MAD1 and CTCF to the hTERT regulatory region. Depletion of CTCF using siRNA reduced the SFN-induced down-regulation of hTERT mRNA transcription in these breast cancer cells. In addition, down-regulation of hTERT expression facilitated the induction of cellular apoptosis in human breast cancer cells. SIGNIFICANCE: Collectively, our results provide novel insights into SFN-mediated epigenetic down-regulation of telomerase in breast cancer prevention and may open new avenues for approaches to SFN-mediated cancer prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Histone acetylation and transcriptional regulatory mechanisms
Struhl, K. (1998) · Genes & Development · doi:10.1101/gad.12.5.599 · Cited by 1,815 · cited 2×
“This leads to an open chromatin structure which facilitates the binding of various transcription factors such as c-MYC, MAD1 and CTCF to gene promoters for the activation or repression of genes, including hTERT [17–19].”
BackgroundFahey, J. W., Zhang, Y., & Talalay, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10367 · Cited by 1,376
A Novel Mechanism of Chemoprotection by Sulforaphane
Myzak, M. C., Karplus, P. A., Chung, F.-L., & Dashwood, R. H. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1326 · Cited by 494
Choi, K.-C., Jung, M. G., Lee, Y.-H., Yoon, J. C., Kwon, S. H., Kang, H.-B., Kim, M.-J., Cha, J.-H., Kim, Y. J., Jun, W. J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2442 · Cited by 354
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers
Kyo, S., Takakura, M., Fujiwara, T., & Inoue, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00878.x · Cited by 347
Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc min mice
Myzak, M. C., Dashwood, W. M., Orner, G. A., Ho, E., & Dashwood, R. H. (2006) · The FASEB Journal · doi:10.1096/fj.05-4785fje · Cited by 344
Bioactive Compounds: Historical Perspectives, Opportunities, and Challenges
Patil, B. S., Jayaprakasha, G. K., Chidambara Murthy, K. N., & Vikram, A. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf9000132 · Cited by 342
Sulforaphane induces cell type–specific apoptosis in human breast cancer cell lines
Pledgie-Tracy, A., Sobolewski, M. D., & Davidson, N. E. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0494 · Cited by 335
Xu, D., Popov, N., Hou, M., Wang, Q., Björkholm, M., Gruber, A., Menkel, A. R., & Henriksson, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071043198 · Cited by 325
Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast
Cornblatt, B. S., Ye, L., Dinkova-Kostova, A. T., Erb, M., Fahey, J. W., Singh, N. K., Chen, M.-S. A., Stierer, T., Garrett-Mayer, E., Argani, P., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm049 · Cited by 320
Myzak, M. C., Tong, P. S. L., Dashwood, W., Dashwood, R. H., & Ho, E. (2007) · PubMed · doi:10.3181/00379727-207-2320227 · Cited by 313
Guilleret, I., Yan, P., Grange, F., Braunschweig, R., Bosman, F. T., & Benhattar, J. (2002) · International Journal of Cancer · doi:10.1002/ijc.10593 · Cited by 260 · cited 1×
“Furthermore, unlike most human gene promoters in which CpG island demethylation leads to gene activation, hTERT control region demethylation is associated with transcriptional repression of hTERT expression [40].”
BackgroundDietary Sulforaphane, a Histone Deacetylase Inhibitor for Cancer Prevention
Ho, E., Clarke, J. D., & Dashwood, R. H. (2009) · The Journal of Nutrition · doi:10.3945/jn.109.113332 · Cited by 241
Naasani, I., Oh-hashi, F., Oh‐hara, T., Feng, W. Y., Johnston, J. S., Chan, K., & Tsuruo, T. (2003) · PubMed · Cited by 236
Jew, S., AbuMweis, S. S., & Jones, P. J. H. (2009) · Journal of Medicinal Food · doi:10.1089/jmf.2008.0268 · Cited by 219
Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG
Berletch, J. B., Liu, C., Love, W. K., Andrews, L. G., Katiyar, S. K., & Tollefsbol, T. O. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21417 · Cited by 218
Self-citationZinn, R. L., Pruitt, K., Eguchi, S., Baylin, S. B., & Herman, J. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3396 · Cited by 210
Renaud, S., Loukinov, D., Abdullaev, Z., Guilleret, I., Bosman, F. T., Lobanenkov, V., & Benhattar, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1125 · Cited by 204
Genistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms
Li, Y., Liu, L., Andrews, L. G., & Tollefsbol, T. O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24398 · Cited by 194
Self-citationNian, H., Delage, B., Ho, E., & Dashwood, R. H. (2009) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20454 · Cited by 193
Telomerase activation by histone deacetylase inhibitor in normal cells
Takakura, M., Kyo, S., Sowa, Y., Wang, Z., Yatabe, N., Maida, Y., Tanaka, M., & Inoue, M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.14.3006 · Cited by 175
Münster, P. N., Marchion, D. C., Biçaku, E., Lacevic, M., Kim, J., Centeno, B. A., DAUD, A. I., Neuger, A. M., Minton, S. E., & Sullivan, D. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1930 · Cited by 160
CTCF binds the proximal exonic region of hTERT and inhibits its transcription
Renaud, S., Loukinov, D., Bosman, F. T., Lobanenkov, V., & Benhattar, J. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki989 · Cited by 153
Genetic and epigenetic modulation of telomerase activity in development and disease
Liu, L., Lai, S. R., Andrews, L. G., & Tollefsbol, T. O. (2004) · Gene · doi:10.1016/j.gene.2004.06.011 · Cited by 137
Self-citationHou, M., Wang, X., Popov, N., Zhang, A., Zhao, X., Zhou, R., Zetterberg, A., Björkholm, M., Arsenian‐Henriksson, M., Gruber, A., et al. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5462 · Cited by 135
Shun, M.-C., Yu, W., Gapor, A., Parsons, R., Atkinson, J., Sanders, B. G., & Kline, K. A. (2004) · Nutrition and Cancer · doi:10.1207/s15327914nc4801_13 · Cited by 111
Anderson, C. J., Hoare, S. F., Ashcroft, M. A., Bilsland, A. E., & Keith, W. N. (2005) · Oncogene · doi:10.1038/sj.onc.1209011 · Cited by 104
Xiao, D., Powolny, A. A., Antosiewicz, J., Hahm, E., Bommareddy, A., Zeng, Y., Desai, D. H., Amin, S., Herman-Antosiewicz, A., & Singh, S. V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9883-5 · Cited by 96
Jacinto, F. V., Ballestar, E., Ropero, S., & Esteller, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2687 · Cited by 93
TAE226‐Induced apoptosis in breast cancer cells with overexpressed Src or EGFR
Golubovskaya, V., Virnig, C., & Cance, W. G. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20380 · Cited by 90
Meeran, S. M., & Katiyar, S. K. (2007) · Experimental Dermatology · doi:10.1111/j.1600-0625.2007.00542.x · Cited by 86
Self-citationSchwab, M., Reynders, V., Loitsch, S. M., Steinhilber, D., Schröder, O., & Stein, J. M. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02834.x · Cited by 82
Suenaga, M., Soda, H., Oka, M., Yamaguchi, A., Nakatomi, K., Shiozawa, K., Kawabata, S., Kasai, T., Yamada, Y., Kamihira, S., et al. (2001) · International Journal of Cancer · doi:10.1002/ijc.10082 · Cited by 81
Dashwood, R. H., & Ho, E. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2008.00065.x · Cited by 74
Ge, Z., Li, W., Wang, N., Liu, C., Zhu, Q., Björkholm, M., Gruber, A., & Xu, D. (2009) · The FASEB Journal · doi:10.1096/fj.09-140087 · Cited by 70
Choi, J., Min, N. Y., Park, J., Kim, J., Park, S. H., Ko, Y. J., Kang, Y., Moon, Y. J., Rhee, S., Ham, S. W., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.11.078 · Cited by 65
Woo, H. J., Lee, S., Choi, B. T., Park, Y., & Choi, Y. H. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.02.004 · Cited by 56
Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells
Bhamre, S., Sahoo, D., Tibshirani, R. J., Dill, D. L., & Brooks, J. D. (2008) · The Prostate · doi:10.1002/pros.20869 · Cited by 50
Telomerase, Telomerase Inhibition, and Cancer
Ahmed, A., & Tollefsbol, T. O. (2003) · Rejuvenation Research · doi:10.1089/109454503323028911 · Cited by 43
Self-citationLiu, L., Berletch, J. B., Green, J. G., Pate, M. S., Andrews, L. G., & Tollefsbol, T. O. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1003.3.8 · Cited by 38
Self-citationMurakami, J., Asaumi, J., Kawai, N., Tsujigiwa, H., Yanagi, Y., Nagatsuka, H., Inoue, T., Kokeguchi, S., Kawasaki, S., Kuroda, M., et al. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0976-x · Cited by 30
Cited by
Dietary Natural Products for Prevention and Treatment of Liver Cancer
Zhou, Y., Li, Y., Zhou, T., Zheng, J., Li, S., & Li, H.-B. (2016) · Nutrients · doi:10.3390/nu8030156 · Cited by 411
Epigenetic diet: impact on the epigenome and cancer
Hardy, T. M., & Tollefsbol, T. O. (2011) · Epigenomics · doi:10.2217/epi.11.71 · Cited by 401
Self-citationReactivity and Stability of Glucosinolates and Their Breakdown Products in Foods
Hanschen, F. S., Lamy, E., Schreiner, M., & Rohn, S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201402639 · Cited by 316
Influences of diet and the gut microbiome on epigenetic modulation in cancer and other diseases
Paul, B., Barnes, S., Demark-Wahnefried, W., Morrow, C., Salvador, C., Skibola, C., & Tollefsbol, T. O. (2015) · Clinical Epigenetics · doi:10.1186/s13148-015-0144-7 · Cited by 306
Self-citationDietary Natural Products for Prevention and Treatment of Breast Cancer
Li, Y., Li, S., Meng, X., Gan, R.-Y., Zhang, J.-J., & Li, H.-B. (2017) · Nutrients · doi:10.3390/nu9070728 · Cited by 304
Metadata
- Authors
- Meeran, S. M., Patel, S. N., & Tollefsbol, T. O.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-07-06
- Volume
- 5
- Issue
- 7
- Pages
- e11457
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2025041464
- Cited by
- 370
- References
- 41
- FWCI
- 9.57
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.